JNK regulates FoxO-dependent autophagy in neurons

Genes and Development

Volumn 25, Issue 4, 2011, Pages 310-322

  Xu, Ping ^a   Das, Madhumita ^a   Reilly, Judith ^a   Davis, Roger J ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Autophagy; Beclin 1; Bnip3; JNK; Neurons

Indexed keywords

BECLIN 1; JANUS KINASE 1; JANUS KINASE 2; JANUS KINASE 3; PROTEIN BCL XL; PROTEIN BNIP3; TRANSCRIPTION FACTOR FOXO;

ARTICLE; AUTOPHAGY; CELL SURVIVAL; CONTROLLED STUDY; ENZYME DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; JANUS KINASE DEFICIENCY; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIAL PROTEINS; NEURONS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

MUS;

EID: 79951720176     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1984311     Document Type: Article

References (77)

1. Barnat M, Enslen H, Propst F, Davis RJ, Soares S, Nothias F. 2010. Distinct roles of c-Jun N-terminal kinase isoforms in neurite initiation and elongation during axonal regeneration. J Neurosci 30: 7804-7816.
2. Barski JJ, Dethleffsen K, Meyer M. 2000. Cre recombinase expression in cerebellar Purkinje cells. Genesis 28: 93-98.
3. Bjorkblom B, Ostman N, Hongisto V, Komarovski V, Filen JJ, Nyman TA, Kallunki T, Courtney MJ, Coffey ET. 2005. Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: Role of microtubule-associated protein 2 as an effector. J Neurosci 25: 6350-6361. (Pubitemid 40962530)
4. Borsello T, Clarke PG, Hirt L, Vercelli A, Repici M, Schorderet DF, Bogousslavsky J, Bonny C. 2003. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat Med 9: 1180-1186. (Pubitemid 37173703)
5. Brecht S, Kirchhof R, Chromik A, Willesen M, Nicolaus T, Raivich G, Wessig J, Waetzig V, Goetz M, Claussen M, et al. 2005. Specific pathophysiological functions of JNK isoforms in the brain. Eur J Neurosci 21: 363-377. (Pubitemid 40204240)
6. Brownlees J, Yates A, Bajaj NP, Davis D, Anderton BH, Leigh PN, Shaw CE, Miller CC. 2000. Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J Cell Sci 113: 401-407. (Pubitemid 30116647)
7. Carboni S, Boschert U, Gaillard P, Gotteland JP, Gillon JY, Vitte PA. 2008. AS601245, a c-Jun NH2-terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils. Br J Pharmacol 153: 157-163.
8. Chang L, Jones Y, Ellisman MH, Goldstein LS, Karin M. 2003. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev Cell 4: 521-533. (Pubitemid 36437559)
9. Chen JT, Lu DH, Chia CP, Ruan DY, Sabapathy K, Xiao ZC. 2005. Impaired long-term potentiation in c-Jun N-terminal kinase 2-deficient mice. J Neurochem 93: 463-473. (Pubitemid 40547503)
10. Coffey ET, Hongisto V, Dickens M, Davis RJ, Courtney MJ. 2000. Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons. J Neurosci 20: 7602-7613.
11. Coffey ET, Smiciene G, Hongisto V, Cao J, Brecht S, Herdegen T, Courtney MJ. 2002. c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons. J Neurosci 22: 4335-4345. (Pubitemid 37465649)
12. Das M, Jiang F, Sluss HK, Zhang C, Shokat KM, Flavell RA, Davis RJ. 2007. Suppression of p53-dependent senescence by the JNK signal transduction pathway. Proc Natl Acad Sci 104: 15759-15764. (Pubitemid 350035373)
13. Davis RJ. 2000. Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252.
14. Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, Flavell RA. 1998. Defective T cell differentiation in the absence of Jnk1. Science 282: 2092-2095. (Pubitemid 29001267)
15. Eagleson KL, Schlueter McFadyen-Ketchum LJ, Ahrens ET, Mills PH, Does MD, Nickols J, Levitt P. 2007. Disruption of Foxg1 expression by knock-in of cre recombinase: Effects on the development of the mouse telencephalon. Neuroscience 148: 385-399. (Pubitemid 47364814)
16. Esneault E, Castagne V, Moser P, Bonny C, Bernaudin M. 2008. D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats. Neuroscience 152: 308-320.
17. Gangwani L, Flavell RA, Davis RJ. 2005. ZPR1 is essential for survival and is required for localization of the survival motor neurons (SMN) protein to Cajal bodies. Mol Cell Biol 25: 2744-2756. (Pubitemid 40381637)
18. Gdalyahu A, Ghosh I, Levy T, Sapir T, Sapoznik S, Fishler Y, Azoulai D, Reiner O. 2004. DCX, a new mediator of the JNK pathway. EMBO J 23: 823-832. (Pubitemid 38418749)
19. Gilley J, Coffer PJ, Ham J. 2003. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 162: 613-622. (Pubitemid 37022939)
20. Griffin JW, Watson DF. 1988. Axonal transport in neurological disease. Ann Neurol 23: 3-13.
21. Grusser-Cornehls U, Baurle J. 2001. Mutant mice as a model for cerebellar ataxia. Prog Neurobiol 63: 489-540. (Pubitemid 32115431)
22. Guertin DA, Sabatini DM. 2007. Defining the role of mTOR in cancer. Cancer Cell 12: 9-22. (Pubitemid 47001784)
23. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, Davis RJ. 1996. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15: 2760-2770. (Pubitemid 26176253)
24. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, et al. 2006. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885-889.
25. Hirt L, Badaut J, Thevenet J, Granziera C, Regli L, Maurer F, Bonny C, Bogousslavsky J. 2004. D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia. Stroke 35: 1738-1743. (Pubitemid 38823657)
26. Hubner A, Barrett T, Flavell RA, Davis RJ. 2008. Multisite phosphorylation regulates Bim stability and apoptotic activity. Mol Cell 30: 415-425. (Pubitemid 351672377)
27. Hubner A, Cavanagh-Kyros J, Rincon M, Flavell RA, Davis RJ. 2010. Functional cooperation of the proapoptotic Bcl2 family proteins Bmf and Bim in vivo. Mol Cell Biol 30: 98-105.
28. Jaeschke A, Karasarides M, Ventura JJ, Ehrhardt A, Zhang C, Flavell RA, Shokat KM, Davis RJ. 2006. JNK2 is a positive regulator of the cJun transcription factor. Mol Cell 23: 899-911. (Pubitemid 44344520)
29. Kabeya Y, Mizushima N, Yamamoto A, Oshitani-Okamoto S, Ohsumi Y, Yoshimori T. 2004. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci 117: 2805-2812. (Pubitemid 38997262)
30. Kennedy NJ, Martin G, Ehrhardt AG, Cavanagh-Kyros J, Kuan CY, Rakic P, Flavell RA, Treistman SN, Davis RJ. 2007. Requirement of JIP scaffold proteins for NMDA-mediated signal transduction. Genes Dev 21: 2336-2346. (Pubitemid 47443339)
31. Kharbanda S, Saxena S, Yoshida K, Pandey P, Kaneki M, Wang Q, Cheng K, Chen YN, Campbell A, Sudha T, et al. 2000. Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage. J Biol Chem 275: 322-327. (Pubitemid 30038988)
32. Khawaja S, Gundersen GG, Bulinski JC. 1988. Enhanced stability of microtubules enriched in detyrosinated tubulin is not a direct function of detyrosination level. J Cell Biol 106: 141-149. (Pubitemid 18051401)
33. Kim AH, Bonni A. 2008. Cdk1-FOXO1: A mitotic signal takes center stage in post-mitotic neurons. Cell Cycle 7: 3819-3822.
34. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, et al. 2008. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4: 151-175. (Pubitemid 351231180)
35. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, et al. 2006. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880-884.
36. Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, Flavell RA. 1999. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22: 667-676. (Pubitemid 29203491)
37. Kuan CY, Whitmarsh AJ, Yang DD, Liao G, Schloemer AJ, Dong C, Bao J, Banasiak KJ, Haddad GG, Flavell RA, et al. 2003. A critical role of neural-specific JNK3 for ischemic apoptosis. Proc Natl Acad Sci 100: 15184-15189. (Pubitemid 37518037)
38. Kuan CY, Schloemer AJ, Lu A, Burns KA, Weng WL, Williams MT, Strauss KI, Vorhees CV, Flavell RA, Davis RJ, et al. 2004. Hypoxia-ischemia induces DNA synthesis without cell proliferation in dying neurons in adult rodent brain. J Neurosci 24: 10763-10772. (Pubitemid 39557651)
39. Lamb JA, Ventura JJ, Hess P, Flavell RA, Davis RJ. 2003. JunD mediates survival signaling by the JNK signal transduction pathway. Mol Cell 11: 1479-1489. (Pubitemid 36776535)
40. Li XM, Li CC, Yu SS, Chen JT, Sabapathy K, Ruan DY. 2007. JNK1 contributes to metabotropic glutamate receptordependent long-term depression and short-term synaptic plasticity in the mice area hippocampal CA1. Eur J Neurosci 25: 391-396.
41. Morel C, Carlson SM, White FM, Davis RJ. 2009. Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis. Mol Cell Biol 29: 3845-3852.
42. Morfini G, Pigino G, Szebenyi G, You Y, Pollema S, Brady ST. 2006. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat Neurosci 9: 907-916. (Pubitemid 43980505)
43. Morfini GA, You YM, Pollema SL, Kaminska A, Liu K, Yoshioka K, Bjorkblom B, Coffey ET, Bagnato C, Han D, et al. 2009. Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat Neurosci 12: 864-871.
44. Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S, Murakami T, Taniguchi M, Tanii I, Yoshinaga K, et al. 2006. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 26: 9220-9231. (Pubitemid 44904418)
45. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, Bjorkoy G, Johansen T. 2007. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282: 24131-24145. (Pubitemid 47328003)
46. Pirianov G, Brywe KG, Mallard C, Edwards AD, Flavell RA, Hagberg H, Mehmet H. 2007. Deletion of the c-Jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxic-ischaemic injury. J Cereb Blood Flow Metab 27: 1022-1032. (Pubitemid 46659033)
47. Podkowa M, Zhao X, Chow CW, Coffey ET, Davis RJ, Attisano L. 2010. Microtubule stabilization by bone morphogenetic protein receptor-mediated scaffolding of c-Jun N-terminal kinase promotes dendrite formation. Mol Cell Biol 30: 2241-2250.
48. Probst GD, Bowers S, Sealy JM, Truong AP, Hom RK, Galemmo RA Jr, Konradi AW, Sham HL, Quincy DA, Pan H, et al. 2011. Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration. Bioorg Med Chem Lett 21: 315-319.
49. Repici M, Centeno C, Tomasi S, Forloni G, Bonny C, Vercelli A, Borsello T. 2007. Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation. Neuroscience 150: 40-49. (Pubitemid 350198685)
50. Sabapathy K, Jochum W, Hochedlinger K, Chang L, Karin M, Wagner EF. 1999. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev 89: 115-124. (Pubitemid 29528280)
51. Salih DA, Brunet A. 2008. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol 20: 126-136.
52. Schulze E, Asai DJ, Bulinski JC, Kirschner M. 1987. Posttranslational modification and microtubule stability. J Cell Biol 105: 2167-2177. (Pubitemid 18019067)
53. Shimizu S, Konishi A, Nishida Y, Mizuta T, Nishina H, Yamamoto A, Tsujimoto Y. 2010. Involvement of JNK in the regulation of autophagic cell death. Oncogene 29: 2070-2082.
54. Sou YS, Waguri S, Iwata JI, Ueno T, Fujimura T, Hara T, Sawada N, Yamada A, Mizushima N, Uchiyama Y, et al. 2008. The Atg8 conjugation system is indispensable for proper development of autophagic isolation membranes in mice. Mol Biol Cell 19: 4762-4775.
55. Tanaka Y, Kanai Y, Okada Y, Nonaka S, Takeda S, Harada A, Hirokawa N. 1998. Targeted disruption of mouse conventional kinesin heavy chain, kif5B, results in abnormal perinuclear clustering of mitochondria. Cell 93: 1147-1158. (Pubitemid 28307420)
56. Tararuk T, Ostman N, Li W, Bjorkblom B, Padzik A, Zdrojewska J, Hongisto V, Herdegen T, Konopka W, Courtney MJ, et al. 2006. JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length. J Cell Biol 173: 265-277.
57. Terrano DT, Upreti M, Chambers TC. 2010. Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis. Mol Cell Biol 30: 640-656.
58. Thomas GM, Lin DT, Nuriya M, Huganir RL. 2008. Rapid and bi-directional regulation of AMPA receptor phosphorylation and trafficking by JNK. EMBO J 27: 361-372. (Pubitemid 351161658)
59. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar- Sagi D, Jones SN, Flavell RA, Davis RJ. 2000. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870-874. (Pubitemid 30257738)
60. Tournier C, Dong C, Turner TK, Jones SN, Flavell RA, Davis RJ. 2001. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes & Dev 15: 1419-1426. (Pubitemid 32524648)
61. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R, Schutz G. 1999. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23: 99-103. (Pubitemid 29418797)
62. Upreti M, Galitovskaya EN, Chu R, Tackett AJ, Terrano DT, Granell S, Chambers TC. 2008. Identification of the major phosphorylation site in Bcl-xL induced by microtubule inhibitors and analysis of its functional significance. J Biol Chem 283: 35517-35525.
63. Waetzig V, Herdegen T. 2005. Context-specific inhibition of JNKs: Overcoming the dilemma of protection and damage. Trends Pharmacol Sci 26: 455-461. (Pubitemid 41207877)
64. Waetzig V, Zhao Y, Herdegen T. 2006. The bright side of JNKsmultitalented mediators in neuronal sprouting, brain development and nerve fiber regeneration. Prog Neurobiol 80: 84-97. (Pubitemid 44692017)
65. Webster DR, Gundersen GG, Bulinski JC, Borisy GG. 1987. Assembly and turnover of detyrosinated tubulin in vivo. J Cell Biol 105: 265-276.
66. Wei Y, Pattingre S, Sinha S, Bassik M, Levine B. 2008. JNK1- mediated phosphorylation of Bcl-2 regulates starvationinduced autophagy. Mol Cell 30: 678-688. (Pubitemid 351818252)
67. Weston CR, Davis RJ. 2007. The JNK signal transduction pathway. Curr Opin Cell Biol 19: 142-149. (Pubitemid 46386399)
68. Whitfield J, Neame SJ, Paquet L, Bernard O, Ham J. 2001. Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron 29: 629-643. (Pubitemid 32323937)
69. Wiegler K, Bonny C, Coquoz D, Hirt L. 2008. The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator. Cerebrovasc Dis 26: 360-366.
70. Xu P, Hashimoto S, Miyazaki H, Asabe K, Shiraishi S, Sueishi K. 1998. Morphometric analysis of the immunohistochemical expression of Clara cell 10-kDa protein and surfactant apoproteins A and B in the developing bronchi and bronchioles of human fetuses and neonates. Virchows Arch 432: 17-25. (Pubitemid 28065835)
71. Yamamoto K, Ichijo H, Korsmeyer SJ. 1999. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19: 8469-8478.
72. Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P, Flavell RA. 1997. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389: 865-870. (Pubitemid 27462982)
73. + T cells to Th1 cells requires MAP kinase JNK2. Immunity 9: 575-585.
74. Yoshida H, Hastie CJ, McLauchlan H, Cohen P, Goedert M. 2004. Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK). J Neurochem 90: 352-358. (Pubitemid 38938221)
75. Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, Baehrecke EH, Lenardo MJ. 2004. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304: 1500-1502. (Pubitemid 38720930)
76. Yuan Z, Becker EB, Merlo P, Yamada T, DiBacco S, Konishi Y, Schaefer EM, Bonni A. 2008. Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons. Science 319: 1665-1668. (Pubitemid 351432504)
77. Zhu Y, Pak D, Qin Y, McCormack SG, Kim MJ, Baumgart JP, Velamoor V, Auberson YP, Osten P, van Aelst L, et al. 2005. Rap2-JNK removes synaptic AMPA receptors during depotentiation. Neuron 46: 905-916. (Pubitemid 40805351)